These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4324612)

  • 1. Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1970 Aug; 45(2):353-63. PubMed ID: 4324612
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial transplantation of methylcholanthrene-treated mammary nodule outgrowth line D1.
    Medina D
    J Natl Cancer Inst; 1972 May; 48(5):1363-70. PubMed ID: 5030953
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of tumorigenicity with morphological progression in a BALB/c preneoplastic outgrowth line.
    Medina D; Kittrell FS
    J Natl Cancer Inst; 1987 Sep; 79(3):569-76. PubMed ID: 3041094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of 3-methylcholanthrene, mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation on the tumor-producing capabilities of the nodule outgrowth line D1.
    Medina D; Faulkin LJ; DeOme KB
    J Natl Cancer Inst; 1970 Jan; 44(1):159-65. PubMed ID: 11515027
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1969 Feb; 42(2):303-10. PubMed ID: 4303882
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone dependence and estradiol receptors in the D series of mammary nodule outgrowth lines and tumors.
    Medina D; Iramain CA; Clark JH
    Cancer Res; 1975 Sep; 35(9):2355-69. PubMed ID: 167955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of the BALB/cNIV mouse strain.
    Young LJ; DeOme KB; Blair PB; Pitelka DR; Cardiff RD
    Cancer Res; 1984 Oct; 44(10):4333-6. PubMed ID: 6088036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of mammary-tumor-virus-free BALB-c mouse mammary nodule outgrowth cells in DNA synthesis to 3-methylcholanthrene tumorigenesis.
    Adamson R; Banerjee MR; Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):899-907. PubMed ID: 5573774
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of mammary tumor virus on the tumor-producing capabilities of nodule outgrowth free of mammary tumor virus.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1968 Jun; 40(6):1303-8. PubMed ID: 4298252
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of dietary phenylalanine deficiency on the mammary tumor virus activity in C3H mice.
    Hui YH; DeOme KB; Briggs GM
    Cancer Res; 1972 Oct; 32(10):2086-8. PubMed ID: 4343007
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.
    Faulkin LJ
    J Natl Cancer Inst; 1966 Feb; 36(2):289-97. PubMed ID: 4286277
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
    Slagle BL; Lanford RE; Medina D; Butel JS
    Cancer Res; 1984 May; 44(5):2155-62. PubMed ID: 6324998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial transplantation of urethan-treated mammary nodule outgrowth line D1.
    Medina D
    J Natl Cancer Inst; 1972 May; 48(5):1371-5. PubMed ID: 4337908
    [No Abstract]   [Full Text] [Related]  

  • 14. Recovery of transformed nodule and ductal mammary cells from carcinogen-treated C57BL mice.
    Guzman RC; Osborn RC; DeOme KB
    Cancer Res; 1981 May; 41(5):1808-11. PubMed ID: 6783300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary role in the growth of metastasizing MRMT-1 mammary carcinoma in rats.
    Harada Y
    Cancer Res; 1976 Jan; 36(1):18-22. PubMed ID: 1247997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodule bioassay of the mouse mammary tumor virus: modifications and quantitative considerations.
    Nandi S; Haslam S; Helmich C; Ritter RI
    J Natl Cancer Inst; 1971 Jun; 46(6):1309-15. PubMed ID: 4325935
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of chemical carcinogen treatment on the immunogenicity of mouse mammary tumors arising from hyperplastic alveolar nodule outgrowth lines.
    Ruppert B; Wei W; Medina D; Heppner GH
    J Natl Cancer Inst; 1978 Oct; 61(4):1165-9. PubMed ID: 100605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pituitary-induced nodular hyperplasia in mammary glands of C3H mice fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    J Natl Cancer Inst; 1971 May; 46(5):929-39. PubMed ID: 4333726
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological and functional properties of TM preneoplastic mammary outgrowths.
    Medina D; Kittrell FS; Liu YJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):663-7. PubMed ID: 7678778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.